Search results
Investors in Regeneron Pharmaceuticals (NASDAQ:REGN) have seen stellar returns of 220% over the past...
Simply Wall St. via Yahoo Finance· 36 minutes agoWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 16 hours agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $1,229.00
ETF DAILY NEWS· 1 day agoRegeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price upped by Royal Bank of Canada from $1,200.00 to $1,229.00 in a research report sent to investors ...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 24 hours agoIt's been a decade since the last innovation in treating chronic obstructive pulmonary disease, or...
Regeneron's Dupixent COPD Sales To Reach $20B By 2026, Analyst Sees Larger Addressable Market - ...
Benzinga· 22 hours agoAnalyst projects Regeneron's Dupixent to drive COPD sales surge, envisioning $20B market by 2026 on larger addressable market.
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Stock's Recent Performance A Reflection Of Its...
Simply Wall St. via Yahoo Finance· 6 days agoRegeneron Pharmaceuticals' (NASDAQ:REGN) stock up by 4.9% over the past month. Since the market...
RBC lifts Regeneron stock PT to $1,229 on higher sales estimetes of Dupixent By Investing.com
Investing.com· 2 days agoOn Wednesday, Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) saw an increase in its price target to...
Why Big-Name Biotech Regeneron Pharma Just Joined The 1,000-Club
Investor's Business Daily· 2 days agoRegeneron stock joined the 1,000-club this month as enthusiasm grows for its blockbuster drug,...
Jacobi Capital Management LLC Boosts Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 2 days agoJacobi Capital Management LLC grew its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 10.5% in the 4th quarter, HoldingsChannel reports. The firm ...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Director Bonnie L. Bassler Sells 827 Shares of Stock
ETF DAILY NEWS· 6 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) Director Bonnie L. Bassler sold 827 shares of the firm’s stock in a transaction dated Wednesday, June 5th.